Features

Tom Freeman on cannabis units, academic careers and on becoming an SSA trustee

Ketamine as a treatment: the SSA talks to Merve Mollaahmetoglu

Ontologies and tobacco, nicotine and vaping products with Sharon Cox

Running a Delphi process on autism and addiction: Betul Aslan talks to the SSA

What impact does opioid agonist treatment have on mortality at a population level?

QMJC June 2022: Timelines and life-grid methods

Opioid agonist treatment modelling with Matt Hickman

Inside the UK’s first unsanctioned drug consumption room

‘Lena left a big impression on me and my practice as a pharmacist’

Can the ‘ageing cohort theory’ account for the increase in drug-related deaths?

QMJC May 2022: Investigating the practice of microdosing psychedelics

The Gay Men’s Health Collective on chemsex, harm reduction, and cultivating more LGBT+ inclusive drug services